Etropal AD (BUL:ETR)

Bulgaria · Delayed Price · Currency is BGN · Price in EUR

2.620

-0.040 (-1.50%)

At close: Aug 31, 2026

Market Cap	25.33M +23.6%
Revenue (ttm)	19.14M +13.3%
Net Income	-132.90K
EPS	-0.03
Shares Out	5.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.21 (4.10%)
Ex-Dividend Date	n/a

Volume	90
Open	2.520
Previous Close	2.660
Day's Range	2.100 - 2.620
52-Week Range	2.044 - 2.760
Beta	-0.01
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 17, 2026

About Etropal AD

Etropal AD engages in the production and sale of disposable medical devices in Bulgaria. The company offers capillary dialyzers; arterial-venous blood line sets; procedure kits; and arterial-venous fistula needles. Etropal AD was founded in 1976 and is headquartered in Etropole, Bulgaria. Etropal AD is a subsidiary of Synthetica AD. [Read more]

Industry Surgical and Medical Instruments and Apparatus

Founded 1976

Employees 100

Stock Exchange Bulgarian Stock Exchange

Ticker Symbol ETR

Full Company Profile

Financial Performance

In 2025, Etropal AD's revenue was 10.35 million, an increase of 28.28% compared to the previous year's 8.07 million. Earnings were 165,736, an increase of 271.63%.

Financial numbers in EUR Financial Statements